Fuzheng Huayu capsule as an adjuvant treatment for HBV-related cirrhosis: A systematic review and meta-analysis.

about

Fuzheng Huayu capsule as an adjuvant treatment for HBV-related cirrhosis: A systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q47299272

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Fuzheng Huayu capsule as an ad ...... atic review and meta-analysis.

@en

Fuzheng Huayu capsule as an ad ...... atic review and meta-analysis.

@nl

type

Item

label

Fuzheng Huayu capsule as an ad ...... atic review and meta-analysis.

@en

Fuzheng Huayu capsule as an ad ...... atic review and meta-analysis.

@nl

prefLabel

Fuzheng Huayu capsule as an ad ...... atic review and meta-analysis.

@en

Fuzheng Huayu capsule as an ad ...... atic review and meta-analysis.

@nl

P1476

Fuzheng Huayu capsule as an ad ...... matic review and meta-analysis

@en

P2093

Haotian Li

http://www.w3.org/2001/XMLSchema#string

Honghong Liu

http://www.w3.org/2001/XMLSchema#string

Jiabo Wang

http://www.w3.org/2001/XMLSchema#string

Kun Li

http://www.w3.org/2001/XMLSchema#string

Lifu Wang

http://www.w3.org/2001/XMLSchema#string

Ping Zhang

http://www.w3.org/2001/XMLSchema#string

Ruilin Wang

http://www.w3.org/2001/XMLSchema#string

Shizhang Wei

http://www.w3.org/2001/XMLSchema#string

Yanling Zhao

http://www.w3.org/2001/XMLSchema#string

Yun Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Ergosterol Is the Active Compound of Cultured Mycelium Cordyceps sinensis on Antiliver Fibrosis.

Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection

Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis.

Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B.

Metabonomic Evaluation of ZHENG Differentiation and Treatment by Fuzhenghuayu Tablet in Hepatitis-B-Caused Cirrhosis.

Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B

Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail

Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis.

P304

757-768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1002/PTR.6009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xuelin Zhou

Tao Wang

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29235181

http://www.w3.org/2001/XMLSchema#string